ACWOC
Actinogen Medical Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Actinogen Medical Limited - Option Expiring 30-Sep-2027
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ACWOC
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ACWOC
N/A
ACWOC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in ACWOC also invest in...
Want more shares? Try these...
AD1 Holdings Ltd. provides an on-line database and search platform to link employers and job candidates. The company is headquartered in Hawthorn, Victoria. The company went IPO on 2016-06-23. The firm builds, manages, and acquires software businesses that develop specialized software solutions to address the specific needs of the global workforce. The firm operates in two main verticals: HR Services and Niche Services. Under HR services the Company provides talent recruitment solutions in the form of ApplyDirect and mentoring products under the Art of Mentoring banner. ApplyDirect provides customer-branded recruitment marketing platforms and related digital services. Jobtale provides a purpose-built recruitment platform that organizations can use to create appealing and informative job ads to attract top talent. Its Utility software services provides a suite of software solutions that support energy retailers to optimize their operations from billing and payments to customer relationship management and end-to-end customer portals.
🙌 Performance (5Yr p.a)
65.00%
📊 Share price
$0.05 AUD
🎥 MEDIA
Audinate Group Ltd. engages in the development and commercialization of audio visual software and hardware. Its principal activity is the development and sale of digital AV networking solutions. Its products include Dante AVIO adapters, software, Dante-enabled products, solutions for manufacturers and solutions for software developers. Dante is a technology platform that distributes digital audio and video signals over computer networks. Dante comprises software and chips, cards and modules that are sold to and integrated inside the AV products of its original equipment manufacturer (OEM) customers. The company also provides a series of products and services for AV professionals, including AVIO adapters and management and control software. Dante replaces all of those connections with a computer network, sending video or hundreds of channels of audio over slender ethernet cables with digital fidelity. Dante is available in over 3,500 products from more than 500 manufacturers.
🙌 Performance (5Yr p.a)
0.17%
📊 Share price
$8.47 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
Acumentis Group Ltd. engages in the provision of valuation, research, and advisory services in relation to property and businesses. The company is headquartered in Sydney, New South Wales. The company went IPO on 2003-12-05. The firm provides commercial and residential valuations, research, and property advice to various homeowners, investors, developers, and lenders. The company offers property valuation, insurance valuation, and advisory services to clients, including banks and financial institutions, property developers, property trusts, government, lawyers, accountants, real estate agents and independent retailers. Its services include quantity surveying, acquisition and compensation, capital gains tax, family law and legal, fund forecasts, illicit substance screening, insurance valuation, litigation and legal advisory services, property buyers’ agencies, self-managed super fund (SMSF) property valuation, stamp duty assessments, tax depreciation schedules and tenant representation. The firm serves property classes such as residential, commercial, rural, agribusiness and government portfolios.
🙌 Performance (5Yr p.a)
-10.25%
📊 Share price
$0.08 AUD
🏠 REAL ESTATE
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.
🙌 Performance (5Yr p.a)
-9.39%
📊 Share price
$0.03 AUD
🧬 BIOTECHNOLOGY